# Ghazaleh Tabatabai

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ghazaleh-tabatabai/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,436 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 63 |
| i10-index | 167 |
| Last Known Institution | German Cancer Research Center |
| OpenAlex ID | https://openalex.org/A5091648075 |
| ORCID iD | https://orcid.org/0000-0002-3542-8782 |
| Works | 530 |

## Researcher papers

- [Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/lomustine-temozolomide-combination-therapy-versus-standard-temozolomide-therapy/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Meningioma and schwannoma management](https://scholariq.org/topics/meningioma-and-schwannoma-management/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [German Cancer Research Center](https://scholariq.org/institutions/german-cancer-research-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.